Provided by Tiger Trade Technology Pte. Ltd.

PharmaCyte Biotech, Inc.

0.6688
+0.00731.10%
Volume:22.24K
Turnover:14.75K
Market Cap:6.78M
PE:-0.60
High:0.6999
Open:0.6999
Low:0.6501
Close:0.6615
52wk High:1.90
52wk Low:0.6300
Shares:10.13M
Float Shares:8.93M
Volume Ratio:0.56
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1141
EPS(LYR):3.19
ROE:-17.68%
ROA:-4.76%
PB:0.19
PE(LYR):0.21

Loading ...

Director Jonathan Schechter Acquires Common Shares of PharmaCyte Biotech Inc

Reuters
·
Jan 08

PharmaCyte Biotech Delays Quarterly Financial Filing

Reuters
·
Dec 16, 2025

PharmaCyte Biotech Inc - Receives Notice of Non-Compliance With Nasdaq Rule - SEC Filing

THOMSON REUTERS
·
Dec 06, 2025

PharmaCyte Biotech : Will Consider All Available Options to Regain Compliance, Including, IF Appropriate, Implementing Reverse Stock Split

THOMSON REUTERS
·
Dec 06, 2025

PharmaCyte Biotech Faces Nasdaq Delisting Risk Over Bid Price Rule Compliance

Reuters
·
Dec 06, 2025

PharmaCyte sells Femasys stake, sees cash position rising to $20M

TIPRANKS
·
Nov 25, 2025

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

THOMSON REUTERS
·
Nov 25, 2025

PharmaCyte Biotech Inc: Plans to Continue Pursuing Value-Accretive Investment Opportunities

THOMSON REUTERS
·
Nov 25, 2025

PharmaCyte Biotech Issues Correction to Financial Statements

Reuters
·
Nov 19, 2025

PharmaCyte Biotech Inc. held a special shareholder meeting

Reuters
·
Nov 01, 2025

PharmaCyte Biotech Inc. Announces Date for Upcoming Special Stockholders Meeting

Reuters
·
Sep 25, 2025

PharmaCyte Biotech Q1 EPS $(1.23) Down From $1.90 YoY

Benzinga
·
Sep 16, 2025

PharmaCyte Biotech Inc. Plans Name Change Following Investment in LightSolver Technology

Reuters
·
Sep 06, 2025

PharmaCyte Biotech Inc - Increases Stake in Tnf Pharmaceuticals by $3 Mln

THOMSON REUTERS
·
Sep 02, 2025

PharmaCyte Biotech Inc. Anticipates Name Change Following TNF Pharmaceuticals Stake Increase

Reuters
·
Sep 02, 2025

Press Release: PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

Dow Jones
·
Sep 02, 2025

PharmaCyte Biotech Inc. Expands Financial Flexibility with $7 Million Financing to Support Strategic Growth

Reuters
·
Aug 20, 2025

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

THOMSON REUTERS
·
Aug 20, 2025

PharmaCyte Biotech Secures $7 Million Through Private Placement Led by Existing Investors

Reuters
·
Aug 18, 2025

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

THOMSON REUTERS
·
Aug 18, 2025